VIVO VENTURES VII LLC 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-13 8:46 pm Sale |
2024-09-30 | 13G | Verona Pharma plc VRNA |
VIVO VENTURES VII LLC | 20,252,688 3.100% |
-2,889,512![]() (-12.49%) |
Filing |
2023-02-13 5:47 pm Purchase |
2022-12-31 | 13G | Verona Pharma plc VRNA |
VIVO VENTURES VII LLC | 23,142,200 3.800% |
23,142,200![]() (New Position) |
Filing |